Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease. Grill JD, Tam S, Thai G, Vides B, et al. Neurology 2025;104:e210152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grill JD, Tam S, Thai G, Vides B, et al. Phase 2A Proof-of-Concept Double-Blind, Randomized, Placebo-Controlled Trial of Nicotinamide in Early Alzheimer Disease. Neurology 2025;104:e210152.
PMID: 39671543